Projects per year
Fingerprint Dive into the research topics where Paul Mullan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 66 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
R3511CNR: Establishment of an Integrated Almac-QUB Drug Discovery Unit at CCRCB
Harrison, T., Harkin, P., Johnston, P., Kennedy, R., Longley, D., Mullan, P., Prise, K., Salto-Tellez, M., Waugh, D., Williams, R. & Wilson, R.
01/08/2012 → 30/04/2016
Project: Research
R1289CNR: Development of a Biomarker for the SRC Pathway in Ovarian Cancer
01/08/2012 → 28/03/2015
Project: Research
R5771CNR: Establishment of an Integrated Almac-QUB Drug Discovery Unit at CCRCB
Waugh, D., Harkin, P., Johnston, P., Kennedy, R., Longley, D., Mullan, P., O'Sullivan, J., Prise, K., Salto-Tellez, M., Williams, R. & Wilson, R.
01/08/2012 → 30/04/2016
Project: Research
Research Output
Development of a novel allograft model of prostate cancer: a new tool to inform clinical translation
Haughey, C. M., Mukherjee, D., Steele, R. E., Popple, A., Dura-Perez, L., Pickard, A., Jain, S., Mullan, P. B., Williams, R., Oliveira, P., Buckley, N. E., Honeychurch, J., Williams, R., McDade, S., Illidge, T., Mills, I. G. & Eddie, S. L., 2020Research output: Other contribution
Open Access
Pin1 plays a key role in the response to treatment and clinical outcome in Triple Negative Breast Cancer
Knowlson, C., Coulter, P., Bingham, V., McQuaid, S., Mullan, P. & Buckley, N. E., 09 Mar 2020, In : Therapeutic Advances in Medical Oncology.Research output: Contribution to journal › Article
Open Access
Defining the molecular evolution of extrauterine high grade serous carcinoma
Beirne, J. P., McArt, D. G., Roddy, A., McDermott, C., Ferris, J., Buckley, N. E., Coulter, P., McCabe, N., Eddie, S. L., Dunne, P. D., O'Reilly, P., Gilmore, A., Feeney, L., Ewing, D. L., Drapkin, R. I., Salto-Tellez, M., Kennedy, R. D., Harley, I. J. G., McCluggage, W. G. & Mullan, P. B., 04 Sep 2019, In : Gynecologic Oncology. 155, 2, p. 305-317 13 p.Research output: Contribution to journal › Article
Fibroblast-derived Gremlin1 localises to epithelial cells at the base of the intestinal crypt
Dutton, L. R., Hoare, O. P., McCorry, A. M. B., Redmond, K. L., Adam, N. E., Canamara, S., Bingham, V., Mullan, P. B., Lawler, M., Dunne, P. D. & Brazil, D. P., 23 Jul 2019, In : Oncotarget. 10, 45, p. 4630-4639 10 p.Research output: Contribution to journal › Article
Open Access
File
1
Citation
(Scopus)
95
Downloads
(Pure)
Identification and SAR exploration of a novel series of Legumain inhibitors
Eddie, S. L., Gregson, A., Graham, E., Burton, S., Harrison, T., Burden, R., Scott, C. J., Mullan, P. B. & Williams, R., 15 Jun 2019, In : Bioorganic & Medicinal Chemistry Letters. 29, 12, p. 1546-1548 3 p.Research output: Contribution to journal › Article
Impact
Development and Commercialization of a Technology Platform to Enable Biomarker Discovery and Validation
Richard Kennedy (Participant), Paul Harkin (Participant), Patrick Johnston (Participant), Alison Hosey (Participant), Julia Miskelly (Participant), Margaret Murray (Participant), Jennifer Quinn (Participant), Colin James (Participant), Jude Mulligan (Participant), Peter Daly (Participant), Paul Mullan (Participant), Julie Mussen (Participant), Ultan McDermott (Participant), Richard Wilson (Participant), Daniel Longley (Participant)
Impact: Health Impact, Quality of Life Impact